Table 5 Nonhaematological toxicity worst course per patient

From: Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours

 

Grade

Toxicity

0

1

2

3

4

Nausea, vomiting

6

4

4

1

0

Fatigue, weakness

3

0

8

4

0

Hypersensitivity

14

1

0

0

0

Transaminases

10

0

0

5

0

Neuropathy

7

5

2

1

0

Alopecia

14

1

0

0

0

Skin

13

2

0

0

0

Back to article page